Can transient elastography, Fib-4, Forns Index, and Lok Score predict esophageal varices in HCV-related cirrhotic patientsα

Gastroenterologia y Hepatologia

Volumn 37, Issue 2, 2014, Pages 58-65

  Hassan, Eman M ^a   Omran, Dalia A ^a   El Beshlawey, Mohamad L ^a   Abdo, Mahmoud ^a   El Askary, Ahmad ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b Ministry of Heath Hospitals   (Egypt)

Author keywords

Esophageal varices; HCV; Liver stiffness measurement; Noninvasive predictors; Serum fibrosis scores

Indexed keywords

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ELASTOGRAPHY; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS VARICES; FEMALE; FIB 4; FORNS INDEX; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; LIVER CIRRHOSIS; LOK SCORE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RIGIDITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TRANSIENT ELASTOGRAHY; AGE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; DIGESTIVE TRACT ENDOSCOPY; ELASTICITY; ESOPHAGEAL AND GASTRIC VARICES; HYPERTENSION, PORTAL; LIVER; PATHOPHYSIOLOGY; PATIENT SELECTION; SEVERITY OF ILLNESS INDEX; THROMBOCYTE COUNT;

CHOLESTEROL;

AGE FACTORS; CHOLESTEROL; CROSS-SECTIONAL STUDIES; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATIENT SELECTION; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84893806210     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2013.09.008     Document Type: Article

References (26)

1. Strickland G.T., Elhefni H., Salman T., Waked I., Abdel-Hamid M., Mikhail N., et al. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 2002, 67:436-442.
2. Sanyal A.J., Fontana R.J., Di Bisceglie A.M., Everhart J.E., Doherty M.C., Everson G.T., et al. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc 2006, 64:855-864.
3. Coelho-Prabhu N., Kamath P.S. Current staging and diagnosis of gastroesophageal varices. Clin Liver Dis 2010, 14:195-208.
4. Chang Y.W. Indication of treatment for esophageal varices: who and whenα. Dig Endosc 2006, 18:10-15.
5. Carbonell N., Pauwels A., Serfaty L., Fourdan O., Lévy V.G., Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 2004, 40:652-659.
6. D'Amico G., De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003, 38:599-612. Cooperative Study Group.
7. Jensen D.M. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 2002, 122:1620-1630.
8. Garcia-Tsao G., Bosch J., Groszmann R. Portal hypertension and variceal bleeding unresolved issues. Summary of an American association for the study of liver diseases and European association for the study of the liver. Single-topic conference. Hepatology 2008, 47:1764-1772.
9. Grace N.D., Groszmann R.J., Garcia-Tsao G., Burroughs A.K., Pagliaro L., Makuch R.W., et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998, 28:868-880.
10. deFranchis R. Updating consensus in portal hypertension. J Hepatol 2000, 33:846-852.
11. Merli M., Nicolini G., Angeloni S., Rinaldi V., De Santis A., Merkel C., et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003, 38:266-272.
12. Vallet-Pichard A., Mallet V., Nalpas B., Verkarre V., Nalpas A., Dhalluin-Venier V., et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV Infection. Comparison with liver biopsy and fibrotest. Hepatology 2007, 46:32-36.
13. Forns X., Ampurdanès S., Llovet J.M., Aponte J., Quintó L., Martínez-Bauer E., et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002, 36:986-992.
14. Lok A.S., Ghany M.G., Goodman Z.D., Wright E.C., Everson G.T., Sterling R.K., et al. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005, 42:282-292.
15. Ziol M., Handra-Luca A., Kettaneh A., Christidis C., Mal F., Kazemi F., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005, 41:48-54.
16. Castera L., Forns X., Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008, 48:835-847.
17. Kettaneh A., Marcellin P., Douvin C., Poupon R., Ziol M., Beaugrand M., et al. Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 2007, 46:628-634.
18. Zaman A., Hapke R.J., Flora K., Rosen H.R., Benner K.G. Changing compliance to the American College of Gastroenterology guidelines for the management of variceal hemorrhage: a regional survey. Am J Gastroenterol 2004, 99:645-649.
19. Castéra L., Le Bail B., Roudot-Thoraval F., Bernard P.H., Foucher J., Merrouche W., et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009, 50:59-68.
20. Bureau C., Metivier S., Peron J.M., Selves J., Robic M.A., Gourraud P.A., et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 2008, 27:1261-1268.
21. Jung H.S., Kim Y.S., Kwon O.S., Ku Y.S., Kim Y.K., Choi D.J., et al. Usefulness of liver stiffness measurement for predicting the presence of esophageal varices in patients with liver cirrhosis. Korean J Hepatol 2008, 14:342-350.
22. Castera L., Pinzani M., Bosch J. Non invasive evaluation of portal hypertension using transient elastography. J Hepatol 2012, 56:696-703.
23. Adler M., Gulbis B., Moreno C., Evrard S., Verset G., Golstein P., et al. The predictive value of FIB-4 versus FibroTest, APRI. FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases. Hepatology 2008, 47:762-763.
24. Patel K., Muir A.J., McHutchison J.G. Validation of a simple predictive model for the identification of mild hepatic fibrosis in chronic hepatitis C patients. Hepatology 2003, 37:1222-1223.
25. Sebastiani G., Tempesta D., Fattovich G., Castera L., Halfon P., Bourliere M., et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum noninvasive markers: results of a multicenter, large-scale study. J Hepatol 2010, 53:630-638.
26. Stefanescu H., Grigorescu M., Lupsor M., Maniu A., Crisan D., Procopet B., et al. A new and simple algorithm for the noninvasive assessment of esophageal varices in cirrhotic patients using serum fibrosis markers and transient elastography. J Gastrointestin Liver Dis 2011, 20:57-64.